These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 34116850)

  • 1. Letter to the editor regarding "The outcome of fluticasone nasal spray on anosmia and triamcinolone oral paste in dysgeusia in COVID-19 patients".
    Verma RR; Gupta N; Singh M
    Am J Otolaryngol; 2021; 42(5):103103. PubMed ID: 34116850
    [No Abstract]   [Full Text] [Related]  

  • 2. The outcome of fluticasone nasal spray on anosmia and triamcinolone oral paste in taste dysgeusia in COVID-19 patients.
    Singh CV; Jain S; Parveen S; Deshmukh P
    Am J Otolaryngol; 2021; 42(4):103009. PubMed ID: 33846030
    [No Abstract]   [Full Text] [Related]  

  • 3. The outcome of fluticasone nasal spray on anosmia and triamcinolone oral paste in dysgeusia in COVID-19 patients.
    Singh CV; Jain S; Parveen S
    Am J Otolaryngol; 2021; 42(3):102892. PubMed ID: 33493729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interest of fluticasone nasal spray in COVID-19 related anosmia is still not demonstrated.
    Lechien JR; Hoch CC; Vaira LA; Saussez S
    Am J Otolaryngol; 2021; 42(4):103008. PubMed ID: 33810883
    [No Abstract]   [Full Text] [Related]  

  • 5. Should anosmia and dysgeusia be a concern for oral and maxillofacial surgeons during the COVID-19 pandemic?
    Alharbi H; You S; Katz J
    Oral Maxillofac Surg; 2022 Mar; 26(1):105-111. PubMed ID: 33954852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 with and without anosmia or dysgeusia: A case-control study.
    Dev N; Sankar J; Gupta N; Meena RC; Singh C; Gupta DK; Sen MK
    J Med Virol; 2021 Apr; 93(4):2499-2504. PubMed ID: 33417259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anosmia and dysgeusia in SARS-CoV-2 infection: incidence and effects on COVID-19 severity and mortality, and the possible pathobiology mechanisms - a systematic review and meta-analysis.
    Mutiawati E; Fahriani M; Mamada SS; Fajar JK; Frediansyah A; Maliga HA; Ilmawan M; Emran TB; Ophinni Y; Ichsan I; Musadir N; Rabaan AA; Dhama K; Syahrul S; Nainu F; Harapan H
    F1000Res; 2021; 10():40. PubMed ID: 33824716
    [No Abstract]   [Full Text] [Related]  

  • 8. Anosmia and dysgeusia associated with SARS-CoV-2 infection: an age-matched case-control study.
    Carignan A; Valiquette L; Grenier C; Musonera JB; Nkengurutse D; Marcil-Héguy A; Vettese K; Marcoux D; Valiquette C; Xiong WT; Fortier PH; Généreux M; Pépin J
    CMAJ; 2020 Jun; 192(26):E702-E707. PubMed ID: 32461325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can symptoms of anosmia and dysgeusia be diagnostic for COVID-19?
    Zahra SA; Iddawela S; Pillai K; Choudhury RY; Harky A
    Brain Behav; 2020 Nov; 10(11):e01839. PubMed ID: 32935915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New loss of smell and taste: Uncommon symptoms in COVID-19 patients on Nord Franche-Comte cluster, France.
    Klopfenstein T; Zahra H; Kadiane-Oussou NJ; Lepiller Q; Royer PY; Toko L; Gendrin V; Zayet S
    Int J Infect Dis; 2020 Nov; 100():117-122. PubMed ID: 32771635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticosteroid nasal spray for recovery of smell sensation in COVID-19 patients: A randomized controlled trial.
    Abdelalim AA; Mohamady AA; Elsayed RA; Elawady MA; Ghallab AF
    Am J Otolaryngol; 2021; 42(2):102884. PubMed ID: 33429174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anosmia and dysgeusia amongst COVID-19 patients are associated with low levels of serum glucagon-like peptide 1.
    Ben-Chetrit E; Ben-Ya'acov A; Quitina A; Atia O; Regev E; Shteyer E; Nashef R
    Int J Clin Pract; 2021 Dec; 75(12):e14996. PubMed ID: 34714940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virucidal activity of nasal sprays against severe acute respiratory syndrome coronavirus-2.
    Meister TL; Todt D; Brüggemann Y; Steinmann J; Banava S; Brill FHH; Steinmann J; Pfaender S; Steinmann E
    J Hosp Infect; 2022 Feb; 120():9-13. PubMed ID: 34752803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of antimicrobial mouthwashes (gargling) and nasal sprays by healthcare workers to protect them when treating patients with suspected or confirmed COVID-19 infection.
    Burton MJ; Clarkson JE; Goulao B; Glenny AM; McBain AJ; Schilder AG; Webster KE; Worthington HV
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD013626. PubMed ID: 32936949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of anosmia and dysgeusia for diagnostic of COVID-19 in outpatients.
    Zayet S; Klopfenstein T; Mercier J; Kadiane-Oussou NJ; Lan Cheong Wah L; Royer PY; Toko L; Gendrin V
    Infection; 2021 Apr; 49(2):361-365. PubMed ID: 32410112
    [No Abstract]   [Full Text] [Related]  

  • 16. Antimicrobial mouthwashes (gargling) and nasal sprays administered to patients with suspected or confirmed COVID-19 infection to improve patient outcomes and to protect healthcare workers treating them.
    Burton MJ; Clarkson JE; Goulao B; Glenny AM; McBain AJ; Schilder AG; Webster KE; Worthington HV
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD013627. PubMed ID: 32936948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence of SARS-CoV-2 and assessment of epidemiologic determinants in Portuguese municipal workers.
    Barros Ferreira N; Pereira H; Pereira AM; Azevedo LF; Santos M; Maranhão P; Correia R; Fonseca JA; Canedo P; da Costa Pereira A; Sousa-Pinto B
    Int J Occup Med Environ Health; 2022 Jun; 35(3):297-307. PubMed ID: 35142298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time course of anosmia and dysgeusia in patients with mild SARS-CoV-2 infection.
    Levinson R; Elbaz M; Ben-Ami R; Shasha D; Levinson T; Choshen G; Petrov K; Gadoth A; Paran Y
    Infect Dis (Lond); 2020 Aug; 52(8):600-602. PubMed ID: 32552475
    [No Abstract]   [Full Text] [Related]  

  • 19. Does COVID-19 cause permanent damage to olfactory and gustatory function?
    Paolo G
    Med Hypotheses; 2020 Oct; 143():110086. PubMed ID: 32721795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of triamcinolone acetonide nasal aerosol spray and fluticasone propionate aqueous solution spray in the treatment of spring allergic rhinitis.
    Small P; Houle PA; Day JH; Briscoe M; Gold M; Brodarec I; Ham Pong A; Mandl M; Spénard J; Phillips R; Furlan M
    J Allergy Clin Immunol; 1997 Nov; 100(5):592-5. PubMed ID: 9389286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.